Janux Therapeutics, Inc. (JANX) Revenue 2020–2025
Janux Therapeutics, Inc. (JANX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$10.0MFY2025 · since FY2020: $0 → $10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.0M | -5.6% |
| FY2024 | $10.6M | +31.0% |
| FY2023 | $8.1M | -6.1% |
| FY2022 | $8.6M | +136.8% |
| FY2021 | $3.6M | — |
| FY2020 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JANX financial trends
JANX Net incomeJANX Net marginJANX Gross profitJANX Gross marginJANX Operating incomeJANX Operating marginJANX Operating cash flowJANX Free cash flowJANX Capital expendituresJANX Return on equityJANX Stock buybacksJANX Dividends paidJANX Total assetsJANX Total liabilitiesJANX Shareholders’ equityJANX overview →